Amgen posts Phase 3 trial win for Repatha in major cardiovascular events Amgen posts Phase 3 trial win for Repatha in major cardiovascular events Post ContentamgnRead More You might also be interested in reading SEC objects to XRP holders aiding Ripple defense. October 2, 2025 In Mainstream ← Previous post Next post →